Download PDF
1 / Pages

Other users also viewed these articles

Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina Federico Guillermo Villamil; Manuel Barbero; Nancy Elena Massenzio; Sandra Mónica Giani; Shigeru Kozima; Fernando Mario Cairo; Rodrigo Agustín Belloni; Javier Mariani; Mercedes Rodriguez Gazari; Paola Evangelina Coisson; Sonia Carolina Gallardo; Paula Andrea Cocco; Claudia Mabel Riboldi; Patricia Eugenia Gallardo;
Ann Hepatol. 2023;28:
New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD Louise Torres; Alice Schuch; Larisse Longo; Bruna Bressan Valentini; Gabriela Schneider Galvão; Eduardo Luchese; Carlos Pinzon; Rodrigo Bartels; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28:
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease Toshiya Machida; Taku Obara; Makoto Miyazaki; Jun Inoue; Nariyasu Mano;
10.1016/j.aohep.2022.100699